From: Thiamine transporter-2 deficiency: outcome and treatment monitoring
Number of patients | Number of patients | ||
---|---|---|---|
Patients | 69 | Dead patients | 23 |
Age (years ± SD) | 3.5 ± 4.3 | Symptoms at follow up | |
Male/Female | 36/33 | Tetraparesia/Dystonia | 32 |
Trigger events | 40 | Cognitive impairment | 23 |
Symptoms at onset | Dysphagia | 13 | |
Encephalopathy/Lethargy | 57 | Epilepsy | 11 |
Seizure | 47 | Dysarthria | 10 |
Generalized and focal dystonia | 38 | Respiratory support | 4 |
Dysarthria/Anarthria | 28 | Ataxia | 3 |
Ataxia | 25 | ||
Dysphagia | 21 | MRI | |
Pyramidal signs | 19 | Caudate | 55 |
Abnormal ocular movement | 17 | Putamen | 55 |
Developmental delay | 12 | Thalami | 31 |
Opisthotonus | 11 | Cerebellum | 22 |
Rigidity/Rigid akinetic syndrome | 11 | Brainstem | 19 |
Tremor | 4 | Subcortical WM | 16 |
Chorea | 2 | Cerebral cortex | 13 |
Jitteriness | 2 | Globus pallidus | 8 |
Dystonic status | 2 | Medulla | 3 |
Dysautonomia | 2 | Lactate on spectroscopy | 6 |
Ptosis | 2 |